Morinda citrifolia (Noni) has been used for centuries to cure or prevent variety of illnesses by traditional medical practitioners in Hawaii and Polynesia. The aim and objective of the present study is to perform GC-MS analysis of Morinda citrifolia fruit extract and in-silico docking analysis of the phytoconstituents identified in Morinda citrifolia fruit extract against targets for antipsychotic drugs like dopamine receptors (D2 and D3). GC-MS analysis was performed and the phytoconstituents of Morinda citrifolia were retrieved from pubchem compound databases. The standard typical antipsychotic and atypical antipsychotic drugs were obtained from drug bank in .mol format. The 3D protein structures of the targets dopamine receptor D2 (PDB ID: 5AER), dopamine receptor D3 (PDB ID: 3PBL) are obtained from Protein Data Bank. In-silico docking analysis was performed by using Molegro virtual docker (MVD). The phytoconstituents with least MolDock score and hydrogen bond interactions shows maximum affinity for the target. The antipsychot ic activity of the phytoconstituents of medicinal plants is analyzed by docking score and binding energy. The phytoconstituents from Morinda citrifolia exhibited the binding pattern to that of the standard drugs exhibiting antipsychotic activity by inhibiting D2 and D3 dopamine receptors.
INTRODUCTION
Schizophrenia is considered to be a neurodevelopmental disease and is suggested to be associated with excessive stimulation of dopamine D 2 receptors in the associative striatum, with a lack of stimulation of dopamine D 1 receptors in prefrontal cortex however the primary process connected with this disease remains indecisive (Laruelle, 2014) . The unexpected discovery in the 1950s, that confirmed that chlorpromazine a phenothiazine derivative, was an effective antipsychotic, is often said to be one of the greatest advances of 20 th century medicine and dramatically changed the treatment and outcome of schizophrenia. It set in motion a wave of drug discovery that resulted in 15 approved antipsychotics in United
States and 40 globally (Gopalakrishna et al., 2016) . Since then, antipsychotic drugs have been the drugs of choice for the treatment of schizophrenia, and about 60 different antipsychotics have been introduced. Although pharmacologically these drugs show large differences, all antipsychotics appear to reduce the positive symptoms of schizophrenia, but unfortunately, have little or no effect on the negative symptoms or the cognitive deficits (Sánchez and Ellenbroek, 2016) . Drugs acting on dopamine receptors (D 1 , D 2 , D 3 , D 4 , and D 5 ) are significant tools for the management of several neuropsychiatric disorders including schizophrenia, bipolar disorder, depression and Parkinson's disease (Beaulieu et al., 2015) . The introduction of the benzodiazepine, clozapine, opened the period of "atypical" antipsychotic drugs, which show a reduced potential to persuade extrapyramidal symptoms (EPS), an augmented effectiveness for the negative symptoms of schizophrenia, no rise of prolactin after persistent use (except risperidone), and effectiveness in some patients formerly regarded as treatment-refractory (Shen, 1999) .
Further there is increasingly strong evidence that D 3 receptor antagonists could be effective antipsychotic agents and could also be involved in behavioural sensitization, with potential efficacy in the treatment of drug abuse (Maramai et al., 2016) .
Morinda citrifolia Linn belongs to the family Rubiaceae and habituated to Sub-himalayan tracts, darjeeling, konkan and the andamans. The Indian Mulberry is commonly known as ashyuka, akshi and atchy in ayurvedic and nunaa, togaru in siddha (Khare, 2008) .
Morinda citrifolia (Noni) has been used for centuries to cure or prevent varieties of illnesses by traditional medical practitioners in Hawaii and Polynesia. It contains phytochemicals that own antibacterial, antiviral, antifungal, antitumor, anthelminthic, analgesic, hypotensive, anti-inflammatory and immune enhancing effects. A complete review on Morinda citrifolia was performed by Assi et al. was carried out in 2016 which described the antimicrobial and antiseptic activity, antifungal activity, antioxidant activity, anti-inflammatory activity, anti-arthritic activity, anti-cancer activity, antidiabetic activity, wound healing activity, memory enhancing activity, anxiolytic and sedative activity, analgesic activity, gastric ulcer healing activity, antiemetic activity, gout and hyperuricemia healing activity, immunity enhancing activity, anti-viral activity, anti-parasitic activity, anti-tuberculosis activity, osteoporotic and otoscopic enhancer. These activities were carried out to the extent of in-vitro, in-vivo and clinical trial stages (Assi et al., 2016) .
In our previous study we reported the antiulcer (Muralidharan and Srikanth, 2010) and antiepileptic activity of Morinda citrifolia (Srikanth and Muralidharan, 2009 (Pandy et al., 2012) . The present study is focused to identify the phytoconstituents in Morinda citrifolia which may be responsible for antipsychotic activity.
EXPERIMENTAL

Plant material and Sample preparation
The full spectrum standardised extract of Morinda citrifolia fruit was obtained from Amsar Goa Pvt Ltd, Goa. The plant was authenticated by Dr Laxmi Morajkar, Head Ayurveda Division (Voucher specimen Number: AGPL/039/13-14). The lyophilized powder was made soluble in ethanol and the GC-MS analysis of the compound was performed. 1.0 g of the lyophilized powdered Morinda citrifolia was soaked in 10 ml of ethanol for 12 hrs. The extract is vortex and filtered. 1.0 µl of this filtered solution was injected for GC-MS analysis.
GC-MS analysis
GC-MS analysis of the extract of Morinda citrifolia was performed using a Thermo Scientific TRACE Ultra Gas Chromatograph interfaced to a TSQ Quantum Ultra™ Triple Quadrupole Mass Spectrometer (GC-MS) equipped with Trace GOLD TG-5MS GC Columns (5% diphenyl 95% dimethyl polysiloxae) fused a capillary column (30 × 0.25 μm ID × 0.25 μm df). Helium (99.999%) was used as the carrier gas with a flow rate of 1 ml/min in the split less mode. An aliquot of 1 µl of ethanol solution of the sample was injected into the column. The oven temperature was programmed from 80 °C (isothermal for 0.0 min), with an increase of 5.0°C/min, to 300°C ending with an isothermal at 300°C for 2.0 min. The injector and auxiliary temperatures were set at 300ºC and 280 o C respectively. Ion source temperature was maintained at 225 o C. The mass spectrum of compounds in samples was obtained by electron ionization at 70 eV and the detector was operated in scan mode from 35-500 m/z. The total running time was 46 minutes. The relative percentage amount of each component was calculated by comparing its average peak area to the total areas (Ezhilan and Neelamegam, 2012) .
Identification of Phytoconstituents
Interpretation on mass-spectrum GC-MS was conducted using the database of National Institute Standard and Technology (NIST) library having more than 62,000 patterns Identification was based on the molecular structure, molecular mass and calculated fragments along with the probability (Linstrom and Mallard, 2016) .
Molecular docking study Preparation of ligand
The 3D structures of the phytoconstituents from Morinda citrifolia identified in GC-MS analysis and selected for docking study were obtained from PubChem compound database (Kim et al., 2016) and saved in .mol format. The standard drugs typical antipsychotic (Chlorpromazine, Haloperidol) and atypical antipsychotic drugs (Amisulpride, Aripiprazole, Clozapine, Risperidone, Paliperidone and Pimozide) were obtained from Drugbank database (Wishart et al., 2006) and saved in .mol format. The ligands both the phytoconstituents and the standard drug were imported to the workspace of Molegro virtual docker (MVD) (Thomsen and Christensen, 2006) and prepared for further docking procedure. The docking scores and docking pattern of the active constituents are compared against the standard drugs.
Preparation of protein (receptors)
The targets for docking studies were selected as D 2 and D 3 receptors. The 3D protein structures of the targets dopamine receptor D 2 (PDB ID: 5AER) (Pandalaneni et al., 2015) and dopamine receptor D 3 (PDB ID: 3PBL) (Chien et al., 2010) are obtained from Protein Data Bank (Berman et al., 2000) . It is well known that PDB files often have poor or missing assignments of explicit hydrogen and the PDB file format cannot accommodate bond order information.
Therefore, proper bonds, bond orders, hybridization and charges were assigned using the MVD. The potential binding sites of both the targets were calculated using the built-in cavity detection algorithm implemented in MVD. The search space of the simulation exploited in the docking studies was studied as a subset region of 25.0 Angstroms around the active side cleft. The water molecules are also taken in to consideration and the replaceable water molecules were given a score of 0.50.
The protein surface was created using create surface on the protein in the workspace explorer. In create surface the surface target for PDB ID: 5AER and 3PBL was set as molecular surface with a resolution of 0.7 Å and probe radius of 1.00Å. The surface type colouring was set as electrostatic. The cavities are detected in the protein molecule. Under general settings the molecular surface is set as expanded vanderwaal with maximum number of cavities as 5. The active site of the receptor was identified with the built in software in MVD.
Parameters for Scoring Function MolDock Score
The MolDock scoring function (MolDock Score) used by MVD is derived from the PLP (piecewise linear potential) scoring functions originally proposed by Gehlhaar et al. and later extended by Yang et al. (Gehlhaar et al., 1995; Gehlhaar et al., 1998; Yang and Chen, 2004) . The MolDock scoring function further improves these scoring functions with a new hydrogen bonding term and new charge schemes. The docking scoring function, E score , is defined by the following energy terms: E score = E inter + E intra Where E inter is the ligand-protein interaction energy, E intra is the internal energy of the ligand
RESULTS AND DISCUSSION GC-MS analysis
GC-MS chromatogram of the standardised extract of Morinda citrifolia [ Figure 1 ] showed 16 major peaks indicating the presence of 16 phytochemical constituents. On comparison of the mass spectra of the constituents with the NIST library, the 16 phytocompounds were characterized and identified. The Spectrum of the unknown component was compared with the spectrum of the component stored in the NIST library and the results are tabulated [ Table 1 ]. 
Molecular Docking studies
The phytoconstituents identified in GC-MS analysis and selected for docking studies include alizarin, ascorbic-acid, betacarotene, beta-sitosterol, morindin, morindone, rutin, and scopoletin. The protein selected for docking study includes dopamine receptor D 2 with PDB ID: 5AER which consists of three chains. A chain consists of 183 amino acid residues whereas B and C chain consists of 14 amino acid residues. The protein D 3 dopamine receptor with PDB ID: 3PBL consists of 2 chains with an amino acid residue of 432 and 423 respectively in A and B chain.
Molecular docking studies were performed and the docking results are tabulated [ Table 2 and 3]. The molecular interactions of phytoconstituents along with D 2 and D 3 receptor were compared with that of the standard typical antipsychotic (chlorpromazine, haloperidol) and atypical antipsychotic drugs (amisulpride, aripiprazole, clozapine, risperidone, paliperidone and pimozide). The docking simulation with D 2 Dopamine receptor with PDB ID: 5AER revealed all the interactions involved only the A chain for both the phytoconstituents and standard drugs. The least MolDock score is simulated by rutin followed by pimozide and aripiprazole with a value of -120.52, -116.13 and -115.04 respectively. The maximum hydrogen bond interaction was rendered by the phytoconstituents ascorbic-acid, rutin, morindin, and alizarin with a value of -8.39, -7.56, -5.04 and -4.59 respectively followed by the standard drugs paliperidone and haloperidol with an interaction of -4.52 and -3.23.
The docking simulation with D 3 Dopamine receptor with PDB ID: 3PBL revealed all the interactions involved both A chain and B chain except for the phytoconstituents morindone, alizarin and scopoletin which involved interaction with amino acid residues only of the A chain. The least MolDock score is simulated by rutin with a MolDock score of -143.02 followed by risperidone with a MolDock score of -131.53. The maximum hydrogen bond interaction was rendered by the phytoconstituent morindone with a value of -10.36 followed by the standard drug paliperidone with a hydrogen bond interaction value of -10.10. The docking pattern of ascorbic acid was compared with that of paliperidone on D 2 dopamine receptor (PDB ID: 5AER) and it was observed that the standard drug was able to bind to more amino acid residues than ascorbic acid.
The drug paliperidone was able to bind to amino acid residues Asn 70, Asn 12, Asp 73, Asp 109, Asp 111, Glu 74, Leu 110, Lys 76, Lys 106, Val 71 as ascorbic acid and in addition it was bonded to Asn 112, Asn 119, Asp 123, Glu 120 and Phe 67 as represented in figure 2 and 3. This was reflected in the MolDock score with a value of -114.21 for Paliperidone whereas the MolDock score of ascorbic acid was found to be -69.32. The docking pattern of morindone was compared with that of paliperidone on D 3 dopamine receptor (PDB ID: 3PBL) and it was observed that the standard drug was able to bind amino acid residues in both A and B chain of the receptor. The MolDock score and hydrogen bond energy for morindone was found to be -66.81 and -10.36 and for paliperidone it was found to be -121.16 and -10.10 respectively. This is represented in figure 3 and 4. The docking analysis of standard drugs based on their MolDcok score on the target D 2 dopamine receptor revealed the following ranking with pimozide (-116.13) followed by aripiprazole (-115.04), paliperidone (-114.21), amisulpride (-101.66), risperidone (-96.34), haloperidol (-91.33), chlorpromazine (-83.47), clozapine (-63.74 ).The docking analysis of standard drugs based on their MolDcok score on the target D 3 dopmaine receptor revealed the following ranking with risperidone (-131.53) followed by paliperidone (-121.16 ), amisulpride (-118.18 ), haloperidol (-109.10), pimozide (-103.77), clozapine (-102.58), aripiprazole (-97.04 ) and chlorpromazine (-83.27 ). This revealed that the scoring function reflected the evolution of dopamine receptor antagonist from the first generation antipsychotics and their affinity towards the dopamine receptor.
An ideal psychotropic drug should cure or lessen the pathogenic mechanisms of the disorder that is being treated, and be without unwanted effects (Lingjaerde et al., 1987) . No such ideal drugs have yet been developed. All known psychotropic drugs may cause unwanted effects (Owens, 2014). Antipsychotic drugs are best classified as typical or atypical. The difference is based solely on their ability to cause extrapyramidal side effects, including tardive dyskinesia (Meltzer, 2013) . The development of D 3 -selective antagonists should have the capacity to bind to orthosteric site as well as a secondary binding pocket (Furman et al., 2015) . The important clinical application and potential for selective Dopamine D 3 receptor antagonists lies in the decrease of drug-induced motivation. The selectivity of these antagonists jointly with reduced lipophilicity (minimizing unspecific binding), augmented brain penetration and enhanced physico-chemical profile are all key factors for clinical efficacy and safety (Micheli and Heidbreder, 2013) . Almost all available antipsychotic agents are dopamine D 2 , D 3 , and/or D 4 receptor antagonists (Dunlop and Brandon, 2015) . Three partial agonist compounds have now been permitted for acute psychosis related with schizophrenia by the US Food and Drug Administration (FDA): aripiprazole, brexpiprazole, and cariprazine (Mailman and Murthy, 2010; Roberts et al., 2016) .
Herbal treatments have a role in psychiatric medicine and a number of them have been reported safe and effective in the literature (Stradford et al., 2012) . The alternative medicine serves as potential treatment with less unwanted effects. The phytoconstituents from Morinda citrifolia has provided maximum affinity to the target receptor to that of the standard drugs. Further studies may be carried out to isolate the phytoconstituents from Morinda citrifolia and perform radio ligand binding assay against the dopamine receptors to confirm its anti psychotic activity
